Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin to reduce immunosuppression in sight-threatening uveitis
2014-003119-13Phase 2Completed
- Sponsor
- University College London
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in uveitis comparing Simvastatin + standard treatment with Placebo + standard treatment (2 arms). Primary endpoint: Mean reduction in prednisolone dose at 12 months. Started Jan 2015; status: completed.
02
Drugs
simvastatin
03
Conditions
uveitis
Beyond the preview
Go deeper on 2014-003119-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003119-13.